Buys
Open market- Shares
- +2,725
- Avg price
- $367.79
- Total value
- +$1,002,230
Gail Boudreaux - President and CEO, Director at Elevance Health, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- ELV on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Gail Boudreaux in Elevance Health, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +2,725
- Share %
- 100%
- Total value
- +$1,002,230
Reported holdings for Gail Boudreaux in Elevance Health, Inc.
Form 4 holding
President and CEO, Director
Elevance Health, Inc.
- Security class
- Common Stock
- Shares / value
- 171,976
- Estimated value
- $63,330,162
- Report date
- 17 Jul 2026
- Price
- $368.25
- Ownership
- Direct
Form 4 holding
President and CEO, Director
Elevance Health, Inc.
- Security class
- Common Stock
- Shares / value
- 60
- Estimated value
- $23,203
- Report date
- 17 Jul 2026
- Price
- $386.73
- Ownership
- Shares Held in Spouse's Revocable Trust
Form 4 holding
President and CEO, Director
Elevance Health, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 63,818
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Gail Boudreaux in Elevance Health, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.